Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
SUPRIYA
₹806.95
₹801.00
₹810.20
₹545.50
₹1085.00
Markets Today
Historical Performance
As of 24-08-2026 11:18, Supriya Lifescience Ltd. share price today is ₹0, with a change of ₹-805.45 (-100.00%) from the previous close of ₹805.45. The stock opened at ₹805 and traded between ₹801 and ₹810.2, with a total traded volume of 35864 shares. The company has a market capitalization of ₹6340.4 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1085 and ₹545.5, respectively.
Supriya Lifescience Ltd. valuation metrics include a P/E ratio of 32, and book value of ₹5.30. Profitability indicators show ROE of 17.45% along with a dividend yield of 0.1%. Supriya Lifescience Ltd. has reported revenue of ₹872.55 Cr and net profit of ₹198.37 Cr.
Supriya Lifescience Ltd. technical indicators include Day RSI at 37.74, Day MFI at 41.02, Day ADX at 19.45. Additional indicators include Commodity Channel Index (CCI) at -112.8 and Williams %R at -77.51. Momentum indicators show Day MACD at -20.34, Day MACD Signal Line at -10.78, DayATR at 41.17. Rate of Change indicators for Supriya Lifescience Ltd. include ROC125 at 15.71 and ROC21 at -8.78.
Exponential moving averages include EMA5 at ₹803.1, EMA10 at ₹823.7, EMA12 at ₹829.2, EMA20 at ₹843.3, EMA26 at ₹849.5, EMA50 at ₹850.8, EMA100 at ₹819, EMA200 at ₹773.6. Simple moving averages include SMA5 at ₹795.7, SMA10 at ₹839.8, SMA20 at ₹850.7, SMA30 at ₹851, SMA50 at ₹887.8, SMA100 at ₹801.4, SMA150 at ₹755.5, SMA200 at ₹755.1.
Support levels for Supriya Lifescience are placed at First Support ₹778.87, Second Support ₹769.93, Third Support ₹753.87. Resistance levels are seen at First Resistance ₹803.87, Second Resistance ₹819.93, Third Resistance ₹828.87. Supriya Lifescience Ltd. shareholding pattern shows promoter holding at 68.3%, FII holding at 6.18%, DII holding at 0%, public holding at 20.21%.
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 189.75 | 276.53 | 206.44 | 199.83 | 145.07 |
| Operating Expense | 142.29 | 178.91 | 134.36 | 127.19 | 93.37 |
| Operating Profit | 47.46 | 97.62 | 72.08 | 72.65 | 51.70 |
| Depreciation | 8.94 | 8.50 | 6.82 | 6.64 | 6.45 |
| Interest | 0.37 | 0.47 | 0.49 | 0.42 | 0.51 |
| Tax | 16.75 | 17.90 | 17.24 | 17.89 | 12.62 |
| Net Profit | 24.04 | 74.23 | 49.68 | 50.43 | 34.79 |
₹806.95
↗ Bullish Moving Average
3
↘ Bearish Moving Average
13
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 68.3 | 68.3 | 68.3 | 68.3 | 68.3 | 68.3 |
| FII | 7.2 | 6.8 | 5.5 | 5.2 | 5.2 | 6.2 |
| DII | 4.2 | 4.8 | 5.2 | 5 | 5.7 | 5.3 |
| Public | 20.2 | 20.1 | 21 | 21.5 | 20.8 | 20.2 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 76.4 K | 1.44 L | 53.06% |
| Week | 2.52 L | 6.7 L | 37.60% |
| 1 Month | 1.51 L | 3.58 L | 42.20% |
| 6 Month | 1.51 L | 4.27 L | 35.43% |
Companies with no Debt
Benjamin Graham Value Screen
Consistent high performing stocks over Five Years
Annual Profit Growth higher than Sector Profit Growth
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 04 Sep, 2025 | 1 | FINAL | 05 Sep, 2025 | Equity Share |
| 20 Sep, 2024 | 0.8 | FINAL | Equity Share | |
| 15 Sep, 2023 | 0.6 | FINAL | Equity Share | |
| 01 Sep, 2022 | 0.6 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹2,148.70 | ₹1,130.25 | ₹1,592.50 | ₹1,530.70 | ₹4,185.10 | ₹779.45 |
| % Change | 0.28% | 1.66% | 5.23% | -0.28% | -0.88% | 3.93% |
| Revenue TTM (₹ Cr) | ₹1,479.07 | ₹675.61 | ₹691.72 | ₹1,543.34 | ₹949.80 | ₹4,501.61 |
| Net Profit TTM (₹ Cr) | ₹199.03 | ₹182.64 | ₹126.37 | ₹-48.62 | ₹266 | ₹291.72 |
| PE TTM | 65.20 | 71.50 | 56.50 | -358.60 | 36.60 | 40.60 |
| 1 Year Return | 99.76 | 95.01 | 121.72 | -17.12 | -19 | 57.13 |
| ROCE | 31.54 | 24.22 | 15.60 | 0.59 | - | 11.40 |
Innova Captab Ltd.
₹ 1075.55
-1.19%
Blue Jet Healthcare Ltd
₹ 609.85
+2.30%
Concord Biotech Ltd.
₹ 1548.50
-1.45%
Aarti Pharmalabs Ltd.
₹ 856.00
+4.80%
Alivus Life Sciences Ltd.
₹ 1347.00
-0.29%
Cohance Lifesciences Ltd.
₹ 453.70
-2.01%
Eris Lifesciences Ltd.
₹ 1319.50
-0.66%
Syngene International Ltd.
₹ 402.05
-1.28%
Alembic Pharmaceuticals Ltd.
₹ 821.75
+0.00%
Sun Pharma Advanced Research Company Ltd.
₹ 198.38
+0.85%
Strides Pharma Science Ltd.
₹ 983.10
-0.31%
FDC Ltd.
₹ 349.95
+0.39%
Shilpa Medicare Ltd.
₹ 844.20
+3.59%
Jubilant Pharmova Ltd.
₹ 893.75
+1.52%
Natco Pharma Ltd.
₹ 885.80
+0.39%
Caplin Point Laboratories Ltd.
₹ 2521.80
-1.52%
Marksans Pharma Ltd.
₹ 321.15
-0.05%
Orchid Pharma Ltd.
₹ 998.95
-0.31%
Viyash Scientific Ltd.
₹ 272.00
-1.43%
AstraZeneca Pharma India Ltd.
₹ 7306.00
-1.48%
Bliss GVS Pharma Ltd.
₹ 570.25
-1.53%
Sanofi India Ltd.
₹ 3327.50
-0.75%
Morepen Laboratories Ltd.
₹ 97.79
+1.85%
Procter & Gamble Health Ltd.
₹ 5891.50
+1.08%
By signing up I certify terms, conditions & privacy policy